| |
Learn about populations at risk of HIV infection |
|
|
|
| |
HIV infection rates vary by patient population.1 How many patients in your practice are at risk of HIV infection?
|
|
| |
|
|
| |
IDENTIFY YOUR PATIENTS AT RISK |
|
| |
|
|
| |
| |
The Centers for Disease Control and Prevention (CDC) report these statistics estimating the number of people in the United States who will contract HIV in their lifetime.1,2
|
|
| |
| |
| MEN WHO HAVE SEX WITH MEN (MSM) |
| |
| Overall |
|
1 in 6 |
 |
| |
| African American |
|
1 in 2 |
 |
| |
| Hispanic/Latino |
|
1 in 4 |
 |
| |
| Caucasian |
|
1 in 11 |
 |
| |
|
|
| |
| |
| HETEROSEXUAL |
|
MEN |
|
WOMEN |
| |
| Overall |
|
1 in 473 |
|
1 in 241 |
| |
|
|
| |
| |
| OVERALL |
|
MEN |
|
WOMEN |
| |
| Overall |
|
1 in 64 |
|
1 in 227 |
| |
| African American |
|
1 in 20 |
|
1 in 48 |
| |
| Hispanic/Latino |
|
1 in 48 |
|
1 in 227 |
| |
| Caucasian |
|
1 in 132 |
|
1 in 880 |
| |
| Injection drug users |
|
1 in 36 |
|
1 in 23 |
| |
|
|
| |
| |
According to these CDC statistics, African American and Hispanic/Latino MSM are at highest risk of contracting HIV. African American women are also disproportionately at risk with a 1 in 48 lifetime risk.1
|
|
| |
| |
The transgender community in the United States is also one of the highest-risk groups for HIV infection: an estimated 22% of transgender women are HIV positive.3
|
|
| |
| |
Although some patient populations may have a higher prevalence of HIV, it is critical to encourage prevention for all your patients.
|
|
| |
| |
|
|
| |
| |
By combining sexual history conversations, routine STI and HIV testing, condoms, and medications as appropriate, you can help protect your patients at risk of HIV infection.4
|
|
| |
| |
| To learn more about HIV prevention, and to register for updates, visit |
|
| |
|
| |
| |
Thank you for your ongoing commitment to HIV prevention,
|
|
| |
| |
The Gilead HIV Prevention Team
|
|
| |
| |
References: 1. Centers for Disease Control and Prevention. 2016 Conference on Retroviruses and Opportunistic Infections. https://www.cdc.gov/nchhstp/newsroom/2016/croi-2016.html. Updated February 24, 2016. Accessed October 5, 2017. 2. Highleyman L. Major disparities persist in lifetime risk of HIV diagnosis in the US. https://www.aidsmap.com/Major-disparities-persist-in-lifetime-risk-of-HIV-diagnosis-in-the-US/page/3038645/. Published February 24, 2016. Accessed October 5, 2017. 3. Centers for Disease Control and Prevention. HIV and transgender communities. http://www.cdc.gov/hiv/pdf/policies/cdc-hiv-transgender-brief.pdf. Published September 2016. Accessed October 5, 2017. 4. Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update. https://stacks.cdc.gov/view/cdc/48352. Published September 2017. Accessed October 16, 2017.
|
|
|
| |
| |
Gilead Website |
Terms of Use |
Privacy Policy |
Contact Us |
Unsubscribe
|
|
| |
| |
|
|
| |
| |
GILEAD, the GILEAD Logo, the Prevention is Reality Logo, and the PreventHIV.com Logo are trademarks of Gilead Sciences, Inc., or one of its related companies. All other marks referenced herein are the property of their respective owners.
© 2017 Gilead Sciences, Inc.
333 Lakeside Drive, Foster City, CA 94404
All rights reserved. UNBP3582 12/17
|
|
| |
